Our objective was to determine whether the addition of human papillomavirus (HPV) testing
to screening cytology improves the detection of cervical cancer precursors. Women of ages …

Since infection with oncogenic human papillomavirus (HPV) has been considered a
necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as …

The validity of testing for high‐risk types of human papillomavirus (HPV) in cervical cancer
prevention programs is undetermined. We compared the performance on primary screening …

Background In the first recruitment phase of a randomized trial of cervical cancer screening
methods (New Technologies for Cervical Cancer Screening [NTCC] study), we compared …

BACKGROUND: To estimate the relationship of human papillomavirus (HPV) detection and
abnormal cytology with histologic diagnoses of cervical precancer and cancer. METHODS …

Use of human papillomavirus (HPV) testing in cervical cancer prevention is increasing
rapidly. A DNA test for 13 HPV types that can cause cervical cancer is approved in the …

The Canadian Cervical Cancer Screening Trial was a randomized controlled trial comparing
the performance of human papillomavirus (HPV) testing and Papanicolaou cytology to …

Background To determine whether testing for DNA of oncogenic human papillomaviruses
(HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we …

Background: Results of cervical cytology screening showing atypical squamous cells of
undetermined significance (ASCUS) or low-grade squamous intraepithelial lesions (LSIL) …

OBJECTIVE: To compare the performance of human papillomavirus (HPV) DNA detection
against routine Papanicolaou smear for the detection of low-and high-grade cervical …